3rd Circ. Revives Suit Against GSK Over Avandia Injury Costs
In a 31-page opinion, a three-judge panel found that the Medicare Secondary Payer Act does indeed hand Medicare Advantage organizations like the Humana plaintiffs, or “secondary payers,” a private cause of action against a “primary payer” like GSK.
“The language of the MSP private cause of action is broad...
Already a subscriber? Click here to login